Skip to main content
CVS
NYSE Life Sciences

CVS Caremark Reverses Course, Restores Coverage for Eli Lilly's Zepbound and Foundayo

Tom Rudovsky · Reported by Dow Jones Newswires
More coverage: Consumer
Sentiment info
Positive
Importance info
8
Price
$92.6
Mkt Cap
$117.475B
52W Low
$58.5
52W High
$98.43
52W Position info
58% above low
Off High info
5.9% below high
Rel. Volume info
0.7× avg
Market data snapshot near publication time

CVS sits 58% above its 52-week low of $58.5.

Summary

CVS Health's pharmacy-benefits management unit, Caremark, is restoring coverage for Eli Lilly's popular weight-loss drug Zepbound, effective October 1st. Additionally, CVS will remove its new-to-market block on Eli Lilly's new oral GLP-1 treatment, Foundayo, effective Monday. This decision reverses a previous move where CVS had favored Novo Nordisk's Wegovy, and follows negotiations that CVS states have led to increased affordability and access to GLP-1s. This is a significant positive for Eli Lilly, as a major PBM restoring coverage will boost market access and sales for its key growth drivers. For CVS, it's a strategic move to enhance its PBM offering and improve customer access to in-demand weight-loss drugs.

At the time of this announcement, CVS was trading at $92.60 on NYSE in the Life Sciences sector, with a market capitalization of approximately $117.5B. The 52-week trading range was $58.50 to $98.43. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Dow Jones Newswires.


Price Chart

Share this article

Copied!

CVS - Latest Insights

CVS
Nov 04, 2026, 1:48 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $80.13
Real-time Price: $81.44 info
Change: +$1.31 (+2%) info
Market Cap: $104.085B info
CVS
Nov 04, 2026, 6:41 AM EST
Source: Reuters
Importance Score:
9
Price at Filing: $93.20
Real-time Price: $81.44 info
Change: -$11.76 (-13%) info
Market Cap: $104.085B info
CVS
Nov 04, 2026, 6:34 AM EST
Filing Type: 8-K
Importance Score:
9
Price at Filing: $91.86
Real-time Price: $81.44 info
Change: -$10.42 (-11%) info
Market Cap: $104.085B info
CVS
Nov 04, 2026, 6:31 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $91.49
Real-time Price: $81.44 info
Change: -$10.05 (-11%) info
Market Cap: $104.085B info
CVS
Nov 04, 2026, 6:30 AM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $91.84
Real-time Price: $81.44 info
Change: -$10.40 (-11%) info
Market Cap: $104.085B info